<DOC>
	<DOCNO>NCT00995072</DOCNO>
	<brief_summary>Beta-blockers ( BB ) important treatment high blood pressure heart disease . However beta-blockers cause sexual dysfunction ( SD ) common side effect limit successful use class medication . Sexual side effect often result drug discontinuation , compromise therapy goal . The investigator conduct study determine nebivolol , new beta blocker selective receptor heart cause vasodilation body cause few sexual side effect , even improve sexual function , compare metoprolol succinate .</brief_summary>
	<brief_title>Comparative Effects Nebivolol Metoprolol Femal Sexual Function</brief_title>
	<detailed_description>This protocol design compare effect two beta blocker , nebivolol ( Bystolic ) 5-10 mg daily metoprolol succinate ( Toprol XL ) 100-200 mg daily sexual function post-menopausal woman high blood pressure . The study compose 2 treatment phase . At baseline subject randomize either nebivolol 5 mg daily metoprolol succinate 100 mg daily . After randomization , subject treat 12 week double blind therapy . Following double-blind therapy subject enter 2-week washout phase subsequently switch alternate therapy . After 4 week ( visit 3 7 ) double-blind treatment either nebivolol 5 mg daily metoprolol succinate 100 mg daily subject evaluate need dosage titration assess . If blood pressure goal dosage study medication double nebivolol 10 mg daily metoprolol succinate 200 mg daily . If blood pressure remain uncontrolled 8 week double blind treatment study medication open label amlodipine 5 mg initiate ( visit 4 8 ) discretion principal investigator . During double blind treatment subject evaluate clinic every 4 week . The primary efficacy variable change baseline Changes Sexual Functioning Questionnaire ( CSFQ ) Female Sexual Function Index ( FSFI ) . The primary study objective determine whether nebivolol cause fewer sexual side effect compare metoprolol succinate nebivolol improve FSF woman . FSF assess questionnaires-FSFI CSFQ .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>1 . Over age 40 year 2 . Postmenopausal ( accord self report 12 consecutive month amenorrhea , serum FSH concentration great 40 international units/L , surgical history consistent menopause ) 3 . In stable monogamous relationship male partner least 6 month 4 . History hypertension , treat untreated 5 . Requirement initiation antihypertensive agent OR addition another antihypertensive medication ( accord principal investigator base clinical judgment ) OR patient require monotherapy antihypertensive wish participate study willing undergo two week washout current antihypertensive therapy 6 . Provide write informed consent prior participation . 1 . Properly measure clinic SBP &gt; 170 mmHg 2 . Advanced AV block 3 . Severe hepatic disease 4 . Heart rate &lt; 55 beats/min ( currently beta blocker therapy ) 5 . Pregnancy lactation 6 . Heart failure ejection fraction less 0.40 7 . History myocardial infarction 8 . History Raynaud 's syndrome 9 . Patients alcoholism recreational drug use exclude due concern ability comply study requirement . 10 . Major psychiatric disorder well control treatment 11 . Spinal cord injury 12 . Severe respiratory disease , opinion investigator contraindicate BB treatment 13 . Poorly control diabetes mellitus ( â‰¥ 9 % ) 14 . Persistent arrhythmia</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>sexual dysfunction</keyword>
	<keyword>female</keyword>
	<keyword>hypertension</keyword>
	<keyword>high blood pressure</keyword>
	<keyword>beta blocker</keyword>
	<keyword>metoprolol</keyword>
	<keyword>nebivolol</keyword>
	<keyword>Bystolic</keyword>
	<keyword>Toprol XL</keyword>
</DOC>